The Biosulin equivalence in standardtherapy ( BEST) study -a multicentre, open-label,non-randomised,inter-ventional ,observational study in subjects using Biosulin 30/70 for thetreatment of insulin-dependent type 1 and type 2 diabetes mellitus

查看全文 作　　者：Segal DG;Tupy D;Distiller LA 出　　处：《SAfr Med J》索引2013年第103卷第7期,共0页